98 related articles for article (PubMed ID: 18757054)
1. Acrolein, IL-6 and CRP as markers of silent brain infarction.
Yoshida M; Tomitori H; Machi Y; Katagiri D; Ueda S; Horiguchi K; Kobayashi E; Saeki N; Nishimura K; Ishii I; Kashiwagi K; Igarashi K
Atherosclerosis; 2009 Apr; 203(2):557-62. PubMed ID: 18757054
[TBL] [Abstract][Full Text] [Related]
2. Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP.
Yoshida M; Higashi K; Kobayashi E; Saeki N; Wakui K; Kusaka T; Takizawa H; Kashiwado K; Suzuki N; Fukuda K; Nakamura T; Watanabe S; Tada K; Machi Y; Mizoi M; Toida T; Kanzaki T; Tomitori H; Kashiwagi K; Igarashi K
Atherosclerosis; 2010 Aug; 211(2):475-9. PubMed ID: 20417516
[TBL] [Abstract][Full Text] [Related]
3. Protein-conjugated acrolein as a biochemical marker of brain infarction.
Igarashi K; Kashiwagi K
Mol Nutr Food Res; 2011 Sep; 55(9):1332-41. PubMed ID: 21732531
[TBL] [Abstract][Full Text] [Related]
4. Use of polyamine metabolites as markers for stroke and renal failure.
Igarashi K; Kashiwagi K
Methods Mol Biol; 2011; 720():395-408. PubMed ID: 21318888
[TBL] [Abstract][Full Text] [Related]
5. Relationship between metabolic disorders and relative risk values of brain infarction estimated by protein-conjugated acrolein, IL-6 and CRP together with age.
Yoshida M; Mizoi M; Saiki R; Kobayashi E; Saeki N; Wakui K; Kusaka T; Takizawa H; Kashiwado K; Suzuki N; Fukuda K; Nakamura T; Watanabe S; Tada K; Tomitori H; Kashiwagi K; Igarashi K
Clin Chim Acta; 2011 Jan; 412(3-4):339-42. PubMed ID: 21070758
[TBL] [Abstract][Full Text] [Related]
6. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke.
Tomitori H; Usui T; Saeki N; Ueda S; Kase H; Nishimura K; Kashiwagi K; Igarashi K
Stroke; 2005 Dec; 36(12):2609-13. PubMed ID: 16269634
[TBL] [Abstract][Full Text] [Related]
7. Acrolein stimulates the synthesis of IL-6 and C-reactive protein (CRP) in thrombosis model mice and cultured cells.
Saiki R; Hayashi D; Ikuo Y; Nishimura K; Ishii I; Kobayashi K; Chiba K; Toida T; Kashiwagi K; Igarashi K
J Neurochem; 2013 Dec; 127(5):652-9. PubMed ID: 23763486
[TBL] [Abstract][Full Text] [Related]
8. Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during stroke.
Yoshida M; Kato N; Uemura T; Mizoi M; Nakamura M; Saiki R; Hatano K; Sato K; Kakizaki S; Nakamura A; Ishii T; Terao T; Murayama Y; Kashiwagi K; Igarashi K
eNeurologicalSci; 2017 Jun; 7():18-24. PubMed ID: 29260020
[TBL] [Abstract][Full Text] [Related]
9. Polyamines and their metabolites as diagnostic markers of human diseases.
Park MH; Igarashi K
Biomol Ther (Seoul); 2013 Jan; 21(1):1-9. PubMed ID: 24009852
[TBL] [Abstract][Full Text] [Related]
10. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction.
Hoshi T; Kitagawa K; Yamagami H; Furukado S; Hougaku H; Hori M
Stroke; 2005 Apr; 36(4):768-72. PubMed ID: 15746456
[TBL] [Abstract][Full Text] [Related]
11. Assessing acrolein for determination of the severity of brain stroke, dementia, renal failure, and Sjögren's syndrome.
Igarashi K; Uemura T; Kashiwagi K
Amino Acids; 2020 Feb; 52(2):119-127. PubMed ID: 30863888
[TBL] [Abstract][Full Text] [Related]
12. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
13. Circulating chemokine levels in febrile infants with serious bacterial infections.
Chen HL; Hung CH; Tseng HI; Yang RC
Kaohsiung J Med Sci; 2009 Dec; 25(12):633-9. PubMed ID: 19951848
[TBL] [Abstract][Full Text] [Related]
14. Functional roles of polyamines and their metabolite acrolein in eukaryotic cells.
Igarashi K; Kashiwagi K
Amino Acids; 2021 Oct; 53(10):1473-1492. PubMed ID: 34546444
[TBL] [Abstract][Full Text] [Related]
15. Intense correlation between brain infarction and protein-conjugated acrolein.
Saiki R; Nishimura K; Ishii I; Omura T; Okuyama S; Kashiwagi K; Igarashi K
Stroke; 2009 Oct; 40(10):3356-61. PubMed ID: 19661476
[TBL] [Abstract][Full Text] [Related]
16. Decrease in acrolein toxicity based on the decline of polyamine oxidases.
Uemura T; Nakamura M; Sakamoto A; Suzuki T; Dohmae N; Terui Y; Tomitori H; Casero RA; Kashiwagi K; Igarashi K
Int J Biochem Cell Biol; 2016 Oct; 79():151-157. PubMed ID: 27590852
[TBL] [Abstract][Full Text] [Related]
17. Association of soluble adhesion molecule and C-reactive protein levels with silent brain infarction in patients with and without type 2 diabetes.
Umemura T; Kawamura T; Sakakibara T; Kanai A; Sano T; Hotta N; Sobue G
Curr Neurovasc Res; 2008 May; 5(2):106-11. PubMed ID: 18473826
[TBL] [Abstract][Full Text] [Related]
18. Toxic acrolein production due to Ca(2+) influx by the NMDA receptor during stroke.
Nakamura M; Uemura T; Saiki R; Sakamoto A; Park H; Nishimura K; Terui Y; Toida T; Kashiwagi K; Igarashi K
Atherosclerosis; 2016 Jan; 244():131-7. PubMed ID: 26630182
[TBL] [Abstract][Full Text] [Related]
19. Correlation between brain damage, associated biomarkers, and medication in psychiatric inpatients: A cross-sectional study.
Yoshida M; Kanzaki T; Mizoi M; Nakamura M; Uemura T; Mimori S; Uju Y; Sekine K; Ishii Y; Yoshimi T; Yasui R; Yasukawa A; Sato M; Okamoto S; Hisaoka T; Miura M; Kusanishi S; Murakami K; Nakano C; Mizuta Y; Mishima S; Hayakawa T; Tsukada K; Kashiwagi K; Igarashi K
Clin Chim Acta; 2017 Jan; 464():50-56. PubMed ID: 27816667
[TBL] [Abstract][Full Text] [Related]
20. Immunological profile of silent brain infarction and lacunar stroke.
Sarchielli P; Nardi K; Chiasserini D; Eusebi P; Tantucci M; Di Piero V; Altieri M; Marini C; Russo T; Silvestrini M; Paolino I; Calabresi P; Parnetti L
PLoS One; 2013; 8(7):e68428. PubMed ID: 23874624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
